Investing.com - Biogen (NASDAQ:BIIB) reported on Wednesday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Biogen announced earnings per share of $4.77 on revenue of $2.78B. Analysts polled by Investing.com anticipated EPS of $4.12 on revenue of $2.67B.
Biogen shares are up 9% from the beginning of the year and are trading at $268.13 , down-from-52-week-high.They are under-performing the Nasdaq 100 which is up 19.57% from the start of the year.
Biogen follows other major Healthcare sector earnings this month
Biogen's report follows an earnings beat by J&J on Tuesday, who reported EPS of $2.6 on revenue of $23.34B, compared to forecasts EPS of $2.36 on revenue of $23.66B.
Intuitive Surgical had beat expectations on Tuesday with third quarter EPS of $1.19 on revenue of $1.4B, compared to forecast for EPS of $1.17 on revenue of $1.39B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar